2015
DOI: 10.1155/2015/816914
|View full text |Cite
|
Sign up to set email alerts
|

Portal Vein Thrombosis due to Prothrombin Gene Mutation following Sleeve Gastrectomy

Abstract: Introduction. Portomesenteric thrombosis is increasingly recognized as a complication of laparoscopic sleeve gastrectomy (LSG). It often presents with abdominal pain. We present a mother and her son who both developed portal vein thrombosis (PVT) after LSG. Case Description. A 43-year-old woman presented complaining of sudden severe abdominal pain, two weeks after she had uncomplicated laparoscopic sleeve gastrectomy. CT scan of the abdomen and pelvis with IV contrast showed portal vein thrombosis and SMV thro… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2016
2016
2023
2023

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(1 citation statement)
references
References 22 publications
(21 reference statements)
0
1
0
Order By: Relevance
“…It can be stated that these mutations are significant risk factors for venous thromboembolism [ 8 , 9 ]. Although cases of thrombosis after different abdominal surgeries have been reported in the presence of Factor 2 heterozygous mutation [ 10 , 11 ], Factor 5 heterozygous mutation has been reported in 6% of liver donors, and this condition carries a small risk of thrombosis after liver transplantation, the relative risk for the development of hepatic vein thrombosis has been reported to be low [ 12 – 14 ]. In terms of hepatic artery and vein thrombosis, which occurs with a rate of 5–15% after liver transplantation, it may be necessary to consider technical reasons in addition to prothrombotic factors [ 12 ].…”
Section: Discussionmentioning
confidence: 99%
“…It can be stated that these mutations are significant risk factors for venous thromboembolism [ 8 , 9 ]. Although cases of thrombosis after different abdominal surgeries have been reported in the presence of Factor 2 heterozygous mutation [ 10 , 11 ], Factor 5 heterozygous mutation has been reported in 6% of liver donors, and this condition carries a small risk of thrombosis after liver transplantation, the relative risk for the development of hepatic vein thrombosis has been reported to be low [ 12 – 14 ]. In terms of hepatic artery and vein thrombosis, which occurs with a rate of 5–15% after liver transplantation, it may be necessary to consider technical reasons in addition to prothrombotic factors [ 12 ].…”
Section: Discussionmentioning
confidence: 99%